Theobald K, Gross-Weege W, Keymling J, König W
Agents Actions. 1987 Feb;20(1-2):10-6. doi: 10.1007/BF01965620.
Recently, we described the presence of a blocking factor (BF) in rat serum, which inhibited the histamine release from rat mast cells in vivo and in vitro. The blocking activity was demonstrated in human serum as well. Qualitative analysis of the purified preparations demonstrated a major component with an apparent molecular weight of 70,000 daltons. In human serum the blocking factor was identified as transferrin (TF) by serological and biochemical methods. BF (DEAE-peak 1) and the iron binding proteins transferrin and lactoferrin (LF) are shown to inhibit the histamine release in vitro. The dose response curves reveal that inhibition by these proteins is dependent on their degree of iron saturation. Furthermore, unlike lactoferrin, the effects of transferrin and BF (DEAE-peak 1) follow the same pattern. Their mechanism of action remains to be elucidated.
最近,我们描述了大鼠血清中存在一种阻断因子(BF),它在体内和体外均能抑制大鼠肥大细胞释放组胺。在人血清中也证实了这种阻断活性。对纯化制剂的定性分析表明,主要成分的表观分子量为70,000道尔顿。通过血清学和生化方法,在人血清中鉴定出阻断因子为转铁蛋白(TF)。已证明BF(DEAE峰1)以及铁结合蛋白转铁蛋白和乳铁蛋白(LF)在体外可抑制组胺释放。剂量反应曲线表明,这些蛋白质的抑制作用取决于其铁饱和度。此外,与乳铁蛋白不同,转铁蛋白和BF(DEAE峰1)的作用模式相同。它们的作用机制仍有待阐明。